Thursday, February 22, 2018 1:17:12 PM
A linkedin bio for Sterling Crockett providing insight into the Agrimed/UNVC partnership.
Sterling Crockett is a visionary leader offering over 30 years of innovative, imperative business practices that create value and masterfully inspire teams to high performance in meeting complex challenges. He is a strategic industrialist whose thoughtful leadership, decisive insight, and experience as chair of five corporations and agencies has made meaningful impacts on corporate governance, infrastructure, and community mentorship on local, national, and international levels.
Most recently, Mr. Crockett assumed the position of General Manager for GTI-Maryland, leading GTI's diversity efforts to secure investments from minority investors, economic benefit, and the campaign to build a medical cannabis cultivation facility in Washington County, Maryland. In October of 2016, He joined with colleagues to found AgriMed Industries, LLC. AgriMed’s mission is to perform high quality cultivation, processing and research of medical cannabis and industrial hemp.
Committed to aiding our nation’s troops, Mr. Crockett has served as Chairman, Senior Financial Officer, and Board Treasurer for R4 Incorporated, a multi-specialty company that services disabled veteran-owned contractors and yields engineering, equipment, and field support in Iraq, Afghanistan, Germany, and Africa. Overseeing more than 300 employees, his work has fostered invigorating strategy for immediate and long-term growth, relationships in legislative government and business community partnerships, and secured a $16.5 billion contract.
He is also the founder of The Coulson Agency, named in honor of his father, Coulson Crockett, who first introduced him to the foundations of entrepreneurship and strong work ethic. The Coulson Agency engages in business consulting, mentorship and direct investment of young organizations to help ensure their success.
https://www.linkedin.com/in/sterling-crockett-16087a133
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM